Correlation Between CYP2C19 Genotype, Level Of Clopidogrel Metabolite And Platelet Inhibition Status

Platelet Function Assessment for Atherothrombotic Patients

NCT00513149 ·Status: UNKNOWN ·Phase: PHASE4

Downstream Molecular Signals of P2Y12 Receptors in Hyporeactive Patients Under Clopidogrel Treatment A Possible Mechanism of HOTPR(High On-Treatment Platelet Reactivity)

NCT03190005 ·Status: COMPLETED

Studying the Efficacy of Aspirin & Clopidogrel in Healthy Subjects With Stable Coronary Artery Disease.

NCT01011257 ·Status: WITHDRAWN ·Phase: PHASE4

Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

NCT01823185 ·Status: UNKNOWN ·Phase: PHASE4

Impact of Clopidogrel Dose Adjustment According to Platelet Reactivity Monitoring in Patients With High on Treatment Platelet Reactivity Undergoing Percutaneous Coronary Intervention

NCT01505790 ·Status: COMPLETED ·Phase: PHASE3

Pilot Study on the Effect of High Clopidogrel Maintenance Dosing

NCT01118793 ·Status: COMPLETED

Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease.

NCT04619927 ·Status: UNKNOWN ·Phase: PHASE4

Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy Subjects

NCT01129063 ·Status: COMPLETED ·Phase: PHASE1

The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery Disease

NCT01260584 ·Status: COMPLETED ·Phase: PHASE4

Clopidogrel/Aspirin Interaction Study

NCT01102439 ·Status: COMPLETED ·Phase: PHASE4

Clopidogrel Resistance in Stroke Patients From Different Ethnicities

NCT03806894 ·Status: UNKNOWN

Influence of Clopidogrel on the Pharmacodynamics and Safety of Terbogrel in Healthy Male Subjects

NCT02222987 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

NCT00386191 ·Status: COMPLETED ·Phase: PHASE4

Healthy Volunteer Study of Clopidogrel and Rifampicin

NCT00696566 ·Status: COMPLETED ·Phase: PHASE1

Influence of Clopidogrel on the Pharmacodynamics and Safety of Fradafiban in Healthy Male Subjects

NCT02265289 ·Status: COMPLETED ·Phase: PHASE1

The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization

NCT00644657 ·Status: COMPLETED ·Phase: NA

Clopidogrel Pharmacogenomics Project

NCT01097343 ·Status: COMPLETED ·Phase: PHASE2

Reproducibility and Comparison of Platelet Function Assays With Aspirin and Clopidogrel (MK-0000-167)

NCT01108588 ·Status: COMPLETED ·Phase: PHASE1

Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort

NCT01330589 ·Status: WITHDRAWN ·Phase: NA

Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke

NCT04072705 ·Status: COMPLETED

Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin

NCT01388660 ·Status: UNKNOWN ·Phase: PHASE1

Drug-Drug Interaction Study to Assess the Effects of Multi Dose Clopidogrel on the Pharmacokinetics of Single-Dose K-877 in Healthy Adult Volunteers

NCT02922465 ·Status: COMPLETED ·Phase: PHASE1

Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

NCT00693069 ·Status: COMPLETED ·Phase: PHASE3

A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel

NCT01263093 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Assess the Effect of Clopidogrel on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Male Subjects

NCT03496506 ·Status: COMPLETED ·Phase: PHASE1